Skip to main content
OpenTrials
Completed

NCT Number: NCT04556682

IVL and RA in Treatment of Balloon-crossable Severely Calcified Coronary Lesions

This study to compare periprocedural safety, angiographic success as well as short and long term outcomes of intravascular lithotripsy and rotational atherectomy as a method of severely calcified coronary lesion preparation before DES implantation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Leiden University Medical Center

Leiden, Netherlands

About this study

Coronary artery calcification (CAC) occurs in over 90% of men and 67% of women older than 70 years old .

Severe coronary calcification may be present in about 20% of patients undergoing percutaneous coronary intervention (PCI) .

Coronary calcification may impair stent delivery and expansion and damage the polymer/drug coating, resulting in impaired drug delivery and predispose to restenosis and stent thrombosis.

Intravascular imaging as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are good tools to assess calcium burden, distribution and thickness. Among the two imaging techniques, OCT was found to be more accurate than IVUS in defining calcium burden, calcium area , thickness and calcium length.

Rotational atherectomy (RA) as a method of severely calcified lesions modification before Drug-Eluting-Stent (DES) implantation has shown good outcomes in recent studies. However, its efficacy is reduced in presence of deep calcification.

Recently, intravascular lithotripsy (IVL) has been introduced as a novel modality for severely calcified coronary lesion preparation with good preliminary outcomes .

Currently the two techniques are regularly being used in combination in order to achieve optimal results . Whether IVL is a method equally good (or superior) to rotablation in cases where anatomy does not exclude the use of either technique (for example balloon-crossable, heavily calcified lesions) has not yet been discussed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged >18 years undergoing PCI because of stable angina (uncontrolled symptoms on optimal medical treatment) or post stabilized acute coronary syndrome (ACS).
  • Patients have severe calcification: defined either angiographically or by OCT (or IVUS) as calcium arch >180º in at least one cross section , calcium length >5mm, calcium thickness >0.5 mm (2, 6).
  • Vessel diameter ≥2.5mm and ≤4.0mm .
  • Heavily calcified lesion length less than 40mm.
  • All patients must have been discussed in the heart team of the hospital and accepted for coronary intervention

Exclusion criteria

  • Severe coronary calcification with lesion uncrossable from a balloon.
  • PCIs in the setting of STEMI or NSTEMI with persistent complains.
  • Patients in cardiogenic shock.
  • Heart failure New York Heart Association (NYHA) class IV.

Treatment and study plan

Rotational atherectomy

Device

Device used for severely calcified coronary lesion preparation before stent implantation.

Intravascular Lithotripsy

Device

Device used for severely calcified coronary lesion preparation before stent implantation.

Primary outcomes

  1. Strategy success

    Time frame: Up to one day

    less than 20% in-stent residual stenosis of the target lesion and no postprocedural complications as no-reflow, dissection or perforation.

Secondary outcomes

  1. Major Adverse Cardiac Events

    Time frame: after one year

    composite of Death, stroke, myocardial infarction, stent thrombosis, target vessel revascularization, and hospitalization at long term follow up

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Intravascular Lithotripsy and Rotational Atherectomy in Treatment of Severely Calcified Coronary Lesions

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Sep 21, 2020
Registry last updated
Aug 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.